Intra-Cellular Therapies ITCI
$ 131.87
0.0%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиГодовой отчет за 2024 год
добавлен 21.02.2025
Intra-Cellular Therapies Мультипликаторы 2011-2025 | ITCI
Мультипликаторы по годам Intra-Cellular Therapies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-785.2 | -236.9 | -18.1 | -15.0 | -9.9 | -8.6 | -4.1 | -8.0 | -5.0 | -12.8 | -18.1 | -12.2 | - | - |
P/S |
66.5 | 51.3 | 18.5 | 50.7 | 98.1 | 20913.5 | - | 3201.1 | 1742.9 | 14638.7 | 963.8 | 119.8 | - | - |
EPS |
-0.2 | -0.3 | -2.7 | -3.5 | -3.2 | -2.7 | -2.8 | -2.1 | -2.7 | -2.9 | -1.1 | -1.6 | -3.0 | - |
EV (Enterprise Value) |
13.2 млрд | 6.76 млрд | 4.59 млрд | 4.23 млрд | 2.24 млрд | 1.22 млрд | 624 млн | 766 млн | 541 млн | 1.3 млрд | 506 млн | 293 млн | -12.8 млн | -13.7 млн |
EBITDA per Share |
-1.13 | -1.66 | -2.8 | -3.51 | -3.28 | -2.78 | -2.96 | -2.22 | -2.73 | -2.93 | -1.08 | - | - | - |
EV/EBITDA |
-14.7 | -9.5 | -7.6 | -3.6 | -7.3 | -4.5 | -12.2 | -16.0 | -11.2 | - | - | |||
PEG |
57.76 | 28.19 | -2.84 | -2.24 | -2.51 | 1.52 | -0.12 | 0.38 | 0.65 | -0.07 | 0.58 | -0.0 | - | - |
P/B |
11.5 | 11.4 | 7.1 | 10.2 | 3.4 | 6.5 | 2.0 | 1.7 | 1.5 | 2.8 | 4.6 | 10.4 | - | - |
P/CF |
-181.2 | -54.5 | -17.2 | -16.4 | -9.7 | -9.9 | -5.4 | -9.7 | -6.3 | -13.0 | -24.4 | -14.5 | - | - |
ROE % |
-1.47 | -4.83 | -39.06 | -67.99 | -34.56 | -75.75 | -48.83 | -21.52 | -31.01 | -22.00 | -25.46 | -84.98 | - | - |
ROA % |
-1.24 | -3.92 | -33.95 | -57.99 | -31.65 | -58.81 | -43.43 | -20.74 | -29.94 | -21.65 | -23.41 | -69.88 | - | - |
ROCE % |
-10.16 | -26.95 | -40.18 | -68.36 | -35.20 | -71.65 | -50.56 | -22.49 | -31.25 | -22.14 | -25.70 | -83.08 | - | - |
Current Ratio |
6.3 | 5.3 | 7.6 | 6.8 | 11.9 | 6.4 | 9.8 | 33.0 | 36.9 | 77.2 | 12.4 | 5.6 | - | - |
DSO |
257.0 | 261.4 | 69.5 | 67.3 | 86.1 | - | - | - | 104.1 | 122.5 | 32.6 | 44.9 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
257.0 | 261.4 | 69.5 | 67.3 | 86.1 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
257.0 | 261.4 | 69.5 | 67.3 | 86.1 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Intra-Cellular Therapies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -0.16 | -0.16 | - | -0.25 | -0.45 | -0.46 | - | -0.57 | -0.92 | -0.78 | -1.05 | -0.95 | -0.85 | -0.65 | -0.76 | -0.79 | -0.96 | -0.73 | -0.73 | -0.63 | -0.68 | -0.63 | -0.75 | -0.76 | -0.68 | -0.65 | -0.56 | -0.53 | -0.41 | -0.62 | -0.64 | -0.7 | -0.71 | -0.64 | -0.67 | -0.91 | -0.61 | -0.72 | -0.52 | -0.22 | -0.15 | -0.17 | -0.36 | -0.42 | -0.56 | -0.39 | - | -0.4 | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.21 | - | - | - | -0.51 | - | -0.58 | -0.93 | -0.78 | - | -0.95 | -0.85 | -0.66 | - | -0.8 | -0.97 | -0.75 | - | -0.66 | -0.71 | -0.66 | - | -0.79 | -0.71 | -0.68 | - | -0.54 | -0.43 | -0.64 | - | -0.69 | -0.73 | -0.66 | - | -0.91 | -0.62 | -0.73 | - | -0.22 | -0.16 | -0.17 | - | -0.27 | -0.55 | -0.37 | - | -0.39 | - | - | - | - | - | - |
ROE % |
-10.30 | -12.04 | -17.67 | -18.10 | -25.91 | -29.68 | -34.62 | -28.90 | -49.41 | -57.40 | -57.83 | -57.35 | -46.07 | -38.68 | -35.96 | -34.56 | -46.13 | -55.61 | -65.11 | -75.75 | -67.77 | -62.96 | -55.52 | -48.83 | -42.65 | -34.61 | -26.76 | -21.52 | -22.19 | -25.21 | -29.52 | -31.01 | -29.74 | -28.43 | -24.74 | -22.00 | -28.56 | -27.13 | -26.37 | -25.46 | -38.28 | -48.50 | -70.92 | -84.98 | -150.41 | -225.74 | -199.55 | -90.86 | -90.86 | - | - | - | - | - | - |
ROA % |
-8.64 | -10.03 | -14.80 | -15.48 | -22.32 | -25.78 | -30.45 | -25.81 | -43.31 | -50.28 | -50.60 | -50.11 | -41.08 | -34.96 | -32.86 | -31.65 | -39.34 | -45.53 | -51.55 | -58.81 | -54.06 | -51.81 | -47.36 | -43.43 | -38.43 | -31.65 | -24.96 | -20.74 | -21.40 | -24.33 | -28.49 | -29.94 | -28.83 | -27.69 | -24.20 | -21.65 | -27.28 | -25.53 | -24.55 | -23.41 | -32.73 | -40.61 | -58.68 | -69.88 | -126.81 | -191.88 | -170.35 | -77.85 | -77.85 | - | - | - | - | - | - |
ROCE % |
- | - | - | - | -8.12 | -16.23 | -28.41 | -29.46 | -45.34 | -53.11 | -53.43 | -37.07 | -45.58 | -38.21 | -35.60 | -25.86 | -44.52 | -54.66 | -64.87 | -57.56 | -71.22 | -66.22 | -58.46 | -37.66 | -42.85 | -34.39 | -26.13 | -15.33 | -23.32 | -26.11 | -30.37 | -23.85 | -30.65 | -29.45 | -25.66 | -16.02 | -21.41 | -20.02 | -19.30 | -13.01 | -28.15 | -37.89 | -59.52 | -57.67 | -70.76 | -68.70 | -43.24 | -13.08 | -13.08 | - | - | - | - | - | - |
Current Ratio |
7.4 | 7.5 | 5.1 | 5.3 | 6.1 | 6.7 | 7.6 | 7.7 | 8.1 | 9.1 | 11.4 | 6.8 | 7.9 | 8.7 | 10.8 | 11.9 | 11.9 | 11.9 | 11.9 | 4.5 | 4.5 | 4.5 | 4.5 | 9.1 | 9.1 | 9.1 | 9.1 | 27.6 | 27.6 | 27.6 | 27.6 | 29.0 | 29.0 | 29.0 | 29.0 | 61.6 | 61.6 | 61.6 | 61.6 | 12.4 | 12.4 | 12.4 | 12.4 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
75.8 | 78.3 | 77.2 | - | 71.8 | 73.1 | 75.0 | - | 68.9 | 65.5 | 69.1 | 65.9 | 66.0 | 65.7 | 70.3 | 79.0 | 133.3 | 515.2 | 453.3 | - | - | - | - | - | - | - | - | 56.9 | 101.2 | 51.8 | 77.8 | 87.9 | 1973.5 | 37.7 | - | 91.2 | 46.1 | 48.8 | 1132.2 | 71.5 | 37.9 | 21.5 | 105.5 | 37.1 | 45.9 | 47.7 | 48.6 | - | 36.3 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4665.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8547.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
75.8 | 78.3 | 77.2 | - | 71.8 | 73.1 | 75.0 | - | 68.9 | 65.5 | 69.1 | 65.9 | 66.0 | 65.7 | 70.3 | 79.0 | 133.3 | 515.2 | 5119.2 | - | - | - | - | - | - | - | - | 56.9 | 101.2 | 51.8 | 77.8 | 87.9 | 1973.5 | 37.7 | - | 91.2 | 46.1 | 48.8 | 1132.2 | 71.5 | 37.9 | 21.5 | 105.5 | 37.1 | 45.9 | 47.7 | 48.6 | - | 36.3 | - | - | - | - | - | - |
Финансовый цикл |
75.8 | 78.3 | 77.2 | - | 71.8 | 73.1 | 75.0 | - | 68.9 | 65.5 | 69.1 | 65.9 | 66.0 | 65.7 | 70.3 | 79.0 | 133.3 | 515.2 | -3428.4 | - | - | - | - | - | - | - | - | 56.9 | 101.2 | 51.8 | 77.8 | 87.9 | 1973.5 | 37.7 | - | 91.2 | 46.1 | 48.8 | 1132.2 | 71.5 | 37.9 | 21.5 | 105.5 | 37.1 | 45.9 | 47.7 | 48.6 | - | 36.3 | - | - | - | - | - | - |
Все данные представлены в валюте USD